TENDER PAR-25-286
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
<p>The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applications are sought that will either 1) develop novel brain stimulation devices or 2) significantly enhance, by means of hardware/software improvements, the effectiveness of brain stimulation devices that are currently U.S. Food and Drug Administration (FDA)-approved or cleared. Novel devices should move beyond existing electrical/magnetic stimulation and develop new stimulation techniques capable of increased spatiotemporal precision as well as multi-focal, closed-loop approaches. Applications s
Tender details
- Reference
- PAR-25-286
- Issuing organisation
- Not recorded
- Opportunity type
- Grant opportunity
- Industry
- Other
- Location
- Not recorded
- Closing date
- 7 January 2028
- Document deadline
- Not stated
- Bid security
- Not stated
- Language
- en
- Source-reported status
- Posted (as of 18 November 2026)
- Status from closing date
- Open (7 January 2028)
Source excerpt
Open official sourceOpportunity number: PAR-25-286 Title: Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) Agency: National Institutes of Health Status: POSTED Posting date: 2024-11-21 Application response date: 2028-01-07 Description: <p>The purpose of this Notice of Funding Opportunity (NOFO) is to encourage a
Verified against the retrieved official source recorded as document DOC-US-0026. SHA-256 0d5104d20a467b56e4718f966a481d709d30f34cf887fbe6be08592f3af7be55 (checksum scope: source response).